The global molecular biology enzymes, reagents, and kits market size was valued at USD 20.94 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.65% from 2023 to 2030. The consistently developing technologies in the field of molecular biology have resulted in a significant impact on the life science research that is being directed for the betterment of health and medical conditions. These research activities involving advanced molecular biology technologies are driving the usage of consumables, thus paving the path for designing innovative methods with a wide range of applications. The adaption rate of molecular biology enzymes, reagents, and kits is also increasing due to the growing use of bioinformatics and computational tools for genome analysis and drug discoveries.

The COVID-19 pandemic positively impacted industry growth. Management of the pandemic resulted in the launch of multiple new kits and products by key players. For example, in January 2020, Bio-Rad Laboratories launched its new Sequoia Complete Stranded RNA Library Prep Kit designed for the first step of library preparation during RNA sequencing. This new kit from the company even possessed high compatibility with a wide variety of samples, such as possibly degraded RNA samples during transit. Moreover, the launch of new molecular diagnostic instruments by these market players furthered the usage of these consumables during analysis.

Additionally, scientists strived for developing the biological database of the SARS-CoV2 virus and employed computational methods coupled with sequencing techniques, which consequently led to an increase in the usage of molecular biology enzymes, reagents, and kits. The ever-growing applications of sequencing techniques and the building of huge data sets have revolutionized the study of genomics and molecular biology with excellent accuracy and precision. The advent of NGS enabled cost-effective and time-efficient methods of DNA sequencing. In addition to NGS, third-generation sequencing technology is creating resurgence in genome sequencing and addressing longstanding problems in de-novo genome assembly, haplotype phasing, and analysis of structural variation. In response to the rising demand for sequencing technologies globally, companies are continuously developing and launching their sequencing reagents and kits.

Traditionally, cell and molecular biology research seeks to understand the function of a single gene, gene family, or signal transduction pathway, often through the disruption or modification of single genes. Researchers use signal-based methods such as microscopy, flow cytometry, and protein blotting and molecular assays such as PCR/QPCR, Sanger sequencing, and gene expression arrays.